The Journey of SCAPs (Stem Cells from Apical Papilla), from Their Native Tissue to Grafting: Impact of Oxygen Concentration

Cells. 2022 Dec 16;11(24):4098. doi: 10.3390/cells11244098.

Abstract

Tissue engineering strategies aim at characterizing and at optimizing the cellular component that is combined with biomaterials, for improved tissue regeneration. Here, we present the immunoMap of apical papilla, the native tissue from which SCAPs are derived. We characterized stem cell niches that correspond to a minority population of cells expressing Mesenchymal stromal/Stem Cell (CD90, CD105, CD146) and stemness (SSEA4 and CD49f) markers as well as endothelial cell markers (VWF, CD31). Based on the colocalization of TKS5 and cortactin markers, we detected migration-associated organelles, podosomes-like structures, in specific regions and, for the first time, in association with stem cell niches in normal tissue. From six healthy teenager volunteers, each with two teeth, we derived twelve cell banks, isolated and amplified under 21 or 3% O2. We confirmed a proliferative advantage of all banks when cultured under 3% versus 21% O2. Interestingly, telomerase activity was similar to that of the highly proliferative hiPSC cell line, but unrelated to O2 concentration. Finally, SCAPs embedded in a thixotropic hydrogel and implanted subcutaneously in immunodeficient mice were protected from cell death with a slightly greater advantage for cells preconditioned at 3% O2.

Keywords: SCAPs; apical papilla; engraftment; hypoxia; immunoMap; podosomes; thixotropic hydrogel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cells, Cultured
  • Mesenchymal Stem Cells*
  • Mice
  • Oxygen / metabolism
  • Stem Cells*

Substances

  • Oxygen

Grants and funding

This research was funded by: Fondation “Gueules cassées”, France, N13-2020 and N11-2022; Department STS (Sciences et technologies pour la Santé) of the University of Bordeaux, France, Subvention of the year 2020; CNRS (Centre Nationale de la Recherche Scientifique, France), H.B. employer, and INSERM (Institut National de la Santé et de la Recherche Médicale), France, dotation funding, every year.